0001415889-24-002567.txt : 20240205 0001415889-24-002567.hdr.sgml : 20240205 20240205164552 ACCESSION NUMBER: 0001415889-24-002567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manji Husseini CENTRAL INDEX KEY: 0002009654 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 24596440 MAIL ADDRESS: STREET 1: C/O ALTO NEUROSCIENCE, INC. STREET 2: 369 SOUTH SAN ANTONIO ROAD CITY: LOST ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 form4-02052024_090245.xml X0508 4 2024-02-01 0001999480 Alto Neuroscience, Inc. ANRO 0002009654 Manji Husseini C/O ALTO NEUROSCIENCE, INC. 369 SOUTH SAN ANTONIO ROAD LOS ALTOS CA 94022 true false false false 0 Stock Option (right to buy) 16 2024-02-01 4 A 0 30574 0 A 2034-01-31 Common Stock 30574 30574 D Stock Option (right to buy) 16 2024-02-01 4 A 0 3083 11.884 A 2034-01-31 Common Stock 3083 3083 D The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date. 560 shares underlying the option shall vest on March 31, 2024, and 841 shares underlying the option shall vest on each of June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service through each such vesting date. This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $36,667. /s/ Erin R. McQuade, Attorney-in-Fact 2024-02-05